Description:

Angiogenic Factor Expression During Fractionated Irradiation; ODM derived from: https://clinicaltrials.gov/show/NCT02072720

Link:

https://clinicaltrials.gov/show/NCT02072720

Keywords:
Versions (1) ▾
  1. 1/15/19
Copyright Holder:
See clinicaltrials.gov
Uploaded on:

January 15, 2019

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Primary Esophageal Carcinoma NCT02072720

Eligibility Primary Esophageal Carcinoma NCT02072720

Inclusion Criteria
patients that will receive chemoradiation following cross-schedule before surgery for esophageal carcinoma
ability to give informed consent
age 18 years or older
Exclusion Criteria
pregnancy
evidence of bleeding diathesis, coagulopathy
inflammation of the gi-tract
brain metastases
diastolic/ systolic hypertension, not responding to treatment
arterial thromboembolism in medical history
surgery within the month prior to start of bevacizumab treatment